K254004 is an FDA 510(k) clearance for the VRNT. Classified as Virtual Reality Behavioral Therapy Device For Pain Relief (product code QRA), Class II - Special Controls.
Submitted by Cognifisense, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on April 10, 2026 after a review of 116 days - within the typical 510(k) review window.
This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.5800 - the FDA physical medicine device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.
View all Cognifisense, Inc. devices